LIF產(chǎn)品信息
英文名稱:Leukemia inhibitory factor
中文名稱:白血病抑制因子
靶點(diǎn)別稱:LIF,CDF,DIA,HILDA,MLPLI
物種:Human/Mouse/Rat
屬性:Protein
標(biāo)記:Biotin-labeled/Unconjugated
內(nèi)毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method.
無(wú)菌(Sterility)
The sterility testing was performed by membrane filtration method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
LIF用戶評(píng)價(jià)
LIF分子背景
白血病抑制因子(LIF)是一種白細(xì)胞介素6類細(xì)胞因子,是細(xì)胞中影響細(xì)胞生長(zhǎng)和發(fā)育的蛋白質(zhì)。白血病抑制因子具有多種功能,如膽堿能神經(jīng)元分化、控制干細(xì)胞多能性、骨和脂肪代謝、因子依賴性細(xì)胞系的有絲分裂和促進(jìn)體內(nèi)巨核細(xì)胞的產(chǎn)生。
LIF的去除推動(dòng)干細(xì)胞分化,但它們保留了增殖潛力或多能性。因此,LIF用于小鼠胚胎干細(xì)胞培養(yǎng)。有必要將干細(xì)胞保持在未分化狀態(tài),但是胚胎干細(xì)胞的基因操縱允許LIF非依賴性生長(zhǎng),特別是Nanog基因的過(guò)表達(dá)。人胚胎干細(xì)胞培養(yǎng)不需要LIF。
關(guān)鍵字: LIF;LIF蛋白;LIF重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。